It is prohibited:
to create an embryo for research purposes (Art. 29 para. 1 of the Reproductive Medicine Act of 18 December 19983), to derive stem cells from such an embryo, or to use such cells;
to modify the genetic material in a germ cell (Art. 35 para. 1 of the Reproductive Medicine Act of 18 December 1998), to derive embryonic stem cells from an embryo that has undergone germ line modification, or to use such cells;
to create a clone, a chimera or a hybrid (Art. 36 para. 1 of the Reproductive Medicine Act of 18 December 1998), to derive embryonic stem cells from such an organism, or to use such cells;
to develop a parthenote, to derive embryonic stem cells therefrom, or to use such cells;
to import or export an embryo of the kind specified under Item a or b, or a clone, chimera, hybrid or parthenote.
It is further prohibited:
to use surplus embryos for any purpose other than the derivation of embryonic stem cells;
to import or export surplus embryos;
to derive stem cells from a surplus embryo after the seventh day of its development;
to place in a woman a surplus embryo used for stem cell derivation.